Kavar Capital Partners Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,041
Closed -$190K 176
2019
Q2
$190K Buy
+4,041
New +$186K 0.07% 127
2018
Q3
Sell
-1,164
Closed -$57K 134
2018
Q2
$57K Hold
1,164
0.03% 173
2018
Q1
$73K Buy
+1,164
New +$79.9K 0.04% 160
2017
Q3
Sell
-23,704
Closed -$1.85M 110
2017
Q2
$1.85M Buy
23,704
+975
+4% +$73.6K 1.01% 48
2017
Q1
$1.85M Sell
22,729
-375
-2% -$29.5K 1.03% 44
2016
Q4
$1.66M Buy
23,104
+375
+2% +$27.1K 1.05% 47
2016
Q3
$1.77M Buy
22,729
+7,395
+48% +$598K 1.14% 40
2016
Q2
$1.2M Buy
15,334
+12,620
+465% +$1.01M 0.77% 62
2016
Q1
$222K Sell
2,714
-50
-2% -$4.07K 0.15% 96
2015
Q4
$246K Hold
2,764
0.16% 96
2015
Q3
$212K Buy
2,764
+15
+0.5% +$1.25K 0.15% 99
2015
Q2
$229K Buy
2,749
+35
+1% +$3.09K 0.16% 109
2015
Q1
$245K Hold
2,714
0.21% 95
2014
Q4
$219K Sell
2,714
-401
-13% -$31.7K 0.17% 119
2014
Q3
$233K Hold
3,115
0.2% 118
2014
Q2
$214K Buy
3,115
+51
+2% +$3.47K 0.18% 124
2014
Q1
$214K Hold
3,064
0.18% 124
2013
Q4
$204K Buy
+3,064
New +$187K 0.18% 118

Other funds holding CAH

Kavar Capital Partners Group's CAH Position: Q3 2019 in Review

Kavar Capital Partners Group sold out of Cardinal Health (CAH) in Q3 2019, closing a stake of 4,041 shares — an estimated $190K sold.

Kavar Capital Partners Group first reported a position in CAH in Q4 2013 and held it in 18 quarters. The position peaked at $1.85M in Q1 2017. 664 funds tracked by Wall St. Rank hold CAH as of Q3 2019.

  • Kavar Capital Partners Group reported no remaining Cardinal Health position as of Q3 2019 after selling out during the quarter.
  • Kavar Capital Partners Group sold 4,041 Cardinal Health shares in Q3 2019, an estimated $190K.
  • Kavar Capital Partners Group first reported a position in Cardinal Health in Q4 2013 and held it in 18 quarters.
  • Kavar Capital Partners Group's Cardinal Health position peaked at $1.85M in Q1 2017.
  • 664 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2019.

Based on Kavar Capital Partners Group's 13F filing for Q3 2019, filed 12 Nov 2019.